Depression and Anxiety in Rheumatoid Arthritis

Depression and Anxiety in Rheumatoid Arthritis: Prevalence and Relation With Disease Activity

The primary endpoint of this study is to evaluate the prevalence of anxiety and depressive disorders, and their relationship with disease activity, in patients with rheumatoid arthritis treated with biological drugs

The prevalence of anxiety and depressive disorders will be assesed with the HADS questionnaire at the time of the visit

Inclusion Criteria:

• age >18 years
• diagnosis of rheumatoid arthritis according to 2010 Classification American College of Rheumatology/ European League Against Rheumatism (ACR/EULAR) Criteria
• being able to compile questionnaire
• current treatment with biological disease-modifying antirheumatic drug

Exclusion Criteria:

• Current treatment for anxiety or depressive disorder